FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2907329945> ?p ?o ?g. }

• W2907329945 abstract "Adolescent HIV patients face enormous difficulty in accessing HIV care services. Given their vulnerability to risk-taking behaviour, this group also have worse treatment outcomes compared to other age groups. Poor treatment outcomes will impact negatively on HIV/AIDS management and control particularly in sub-Saharan Africa (SSA) as more than eight out of ten of the world’s HIV-infected adolescents live in this region of the world. Limited evidence exists on the effectiveness of service delivery interventions to support adolescents’ retention on antiretroviral therapy (ART) and adherence to ART. This trial is designed to evaluate the impact of conditional economic incentive and motivational interviewing on adolescents’ retention in HIV care and adherence to ART in Anambra State, Southeast Nigeria. The study will be a cluster randomised controlled trial that will be conducted in selected HIV treatment hospitals in Anambra State, Nigeria. Based on sample size calculation, 12 HIV treatment hospitals from Anambra will be selected for the study. Six HIV treatment hospitals each will be randomised to either the intervention or the control arm. A structured adherence support scheme termed the ‘Incentive Scheme’ will be applied to the intervention arm while the control arm will receive routine HIV care (usual care). Additionally, patients in the intervention arm will receive motivational interviewing at baseline and following initiation of antiretroviral therapy (ART), they will receive a gift voucher of US$5.6 when HIV viral load (VL) is < 20 copies/mL at 12 weeks, a gift voucher of US$2.8 if the VL remains suppressed for the next 3 months, and the next 6 months, and finally a gift voucher of US$5.6 if the VL remains < 20 copies/mL at 1 year. All gift vouchers will be conditional not only on VL results but attending the motivational interviews. The primary outcome for the trial will be the difference between groups in the proportion with HIV VL suppression (≤ 20 copies/mL) by 12 months and then 24 months after withdrawal of incentive. The findings of this proposed trial will provide evidence on the feasibility of applying conditional economic incentives combined with motivational interviewing to improve retention and adherence to antiretroviral therapy of adolescents living with HIV in Nigeria and possibly in other sub-Saharan African countries. Registered in the Pan African Clinical Trials Registry, ID: PACTR201806003040425 . Registered on 2 February 2018." @default.
• W2907329945 created "2019-01-11" @default.
• W2907329945 creator A5021971370 @default.
• W2907329945 creator A5023565426 @default.
• W2907329945 creator A5072797973 @default.
• W2907329945 creator A5076659686 @default.
• W2907329945 creator A5083668009 @default.
• W2907329945 date "2018-12-01" @default.
• W2907329945 modified "2023-09-27" @default.
• W2907329945 title "Conditional economic incentives and motivational interviewing to improve adolescents’ retention in HIV care and adherence to antiretroviral therapy in Southeast Nigeria: study protocol for a cluster randomised trial" @default.
• W2907329945 cites W1615876832 @default.
• W2907329945 cites W1748070681 @default.
• W2907329945 cites W1904518076 @default.
• W2907329945 cites W1976594536 @default.
• W2907329945 cites W1985386799 @default.
• W2907329945 cites W2007598841 @default.
• W2907329945 cites W2007851141 @default.
• W2907329945 cites W2013496549 @default.
• W2907329945 cites W2033853316 @default.
• W2907329945 cites W2069258149 @default.
• W2907329945 cites W2082540690 @default.
• W2907329945 cites W2122328334 @default.
• W2907329945 cites W2142038082 @default.
• W2907329945 cites W2159482187 @default.
• W2907329945 cites W2159667320 @default.
• W2907329945 cites W2160120158 @default.
• W2907329945 cites W2170899200 @default.
• W2907329945 cites W2255457027 @default.
• W2907329945 cites W4292495967 @default.
• W2907329945 doi "https://doi.org/10.1186/s13063-018-3095-4" @default.
• W2907329945 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6311063" @default.
• W2907329945 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30594223" @default.
• W2907329945 hasPublicationYear "2018" @default.
• W2907329945 type Work @default.
• W2907329945 sameAs 2907329945 @default.
• W2907329945 citedByCount "9" @default.
• W2907329945 countsByYear W29073299452020 @default.
• W2907329945 countsByYear W29073299452021 @default.
• W2907329945 countsByYear W29073299452022 @default.
• W2907329945 countsByYear W29073299452023 @default.
• W2907329945 crossrefType "journal-article" @default.
• W2907329945 hasAuthorship W2907329945A5021971370 @default.
• W2907329945 hasAuthorship W2907329945A5023565426 @default.
• W2907329945 hasAuthorship W2907329945A5072797973 @default.
• W2907329945 hasAuthorship W2907329945A5076659686 @default.
• W2907329945 hasAuthorship W2907329945A5083668009 @default.
• W2907329945 hasBestOaLocation W29073299451 @default.
• W2907329945 hasConcept C105458232 @default.
• W2907329945 hasConcept C118552586 @default.
• W2907329945 hasConcept C121955636 @default.
• W2907329945 hasConcept C141071460 @default.
• W2907329945 hasConcept C142462285 @default.
• W2907329945 hasConcept C144133560 @default.
• W2907329945 hasConcept C162324750 @default.
• W2907329945 hasConcept C168563851 @default.
• W2907329945 hasConcept C175444787 @default.
• W2907329945 hasConcept C1862650 @default.
• W2907329945 hasConcept C27415008 @default.
• W2907329945 hasConcept C2777016617 @default.
• W2907329945 hasConcept C2780665704 @default.
• W2907329945 hasConcept C29122968 @default.
• W2907329945 hasConcept C3013748606 @default.
• W2907329945 hasConcept C512399662 @default.
• W2907329945 hasConcept C71924100 @default.
• W2907329945 hasConceptScore W2907329945C105458232 @default.
• W2907329945 hasConceptScore W2907329945C118552586 @default.
• W2907329945 hasConceptScore W2907329945C121955636 @default.
• W2907329945 hasConceptScore W2907329945C141071460 @default.
• W2907329945 hasConceptScore W2907329945C142462285 @default.
• W2907329945 hasConceptScore W2907329945C144133560 @default.
• W2907329945 hasConceptScore W2907329945C162324750 @default.
• W2907329945 hasConceptScore W2907329945C168563851 @default.
• W2907329945 hasConceptScore W2907329945C175444787 @default.
• W2907329945 hasConceptScore W2907329945C1862650 @default.
• W2907329945 hasConceptScore W2907329945C27415008 @default.
• W2907329945 hasConceptScore W2907329945C2777016617 @default.
• W2907329945 hasConceptScore W2907329945C2780665704 @default.
• W2907329945 hasConceptScore W2907329945C29122968 @default.
• W2907329945 hasConceptScore W2907329945C3013748606 @default.
• W2907329945 hasConceptScore W2907329945C512399662 @default.
• W2907329945 hasConceptScore W2907329945C71924100 @default.
• W2907329945 hasFunder F4320338462 @default.
• W2907329945 hasIssue "1" @default.
• W2907329945 hasLocation W29073299451 @default.
• W2907329945 hasLocation W29073299452 @default.
• W2907329945 hasLocation W29073299453 @default.
• W2907329945 hasLocation W29073299454 @default.
• W2907329945 hasLocation W29073299455 @default.
• W2907329945 hasOpenAccess W2907329945 @default.
• W2907329945 hasPrimaryLocation W29073299451 @default.
• W2907329945 hasRelatedWork W2030911861 @default.
• W2907329945 hasRelatedWork W2073502301 @default.
• W2907329945 hasRelatedWork W2130149663 @default.
• W2907329945 hasRelatedWork W2280747152 @default.
• W2907329945 hasRelatedWork W2329503629 @default.
• W2907329945 hasRelatedWork W2941384778 @default.
• W2907329945 hasRelatedWork W2999537197 @default.
• W2907329945 hasRelatedWork W3148248608 @default.
• W2907329945 hasRelatedWork W3184804090 @default.
• W2907329945 hasRelatedWork W3205629545 @default.

• next